Literature DB >> 14125985

EFFECTS OF SELECTED CYTOTOXIC AGENTS ON ANTIBODY PRODUCTION IN MAN; A PRELIMARY REPORT.

G W SANTOS, A H OWENS, L L SENSENBRENNER.   

Abstract

Entities:  

Keywords:  AGGLUTINATION; ANTIBODY FORMATION; CLINICAL RESEARCH; CYCLOPHOSPHAMIDE; FLUORODEOXYURIDINE; FLUOROURACIL; HEMAGGLUTINATION; MECHLORETHAMINE; MERCAPTOPURINE; PASTEURELLA TULARENSIS; SKIN TESTS

Mesh：

Substances：

Year:  1964        PMID： 14125985     DOI： 10.1111/j.1749-6632.1964.tb53594.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  11 in total

Review 1.  Pulmonary infections in immunocompromised children.

Authors:  V P Choudhry; S Choudhary
Journal:  Indian J Pediatr       Date:  1989 Nov-Dec       Impact factor: 1.967

Review 2.  Suppression of the immune response.

Authors:  J Bradley; C J Elson
Journal:  J Med Genet       Date:  1971-09       Impact factor: 6.318

3.  Cyclophosphamide and human organ transplantation.

Authors:  T E Starzl; C G Halgrimson; I Penn; G Martineau; G Schroter; H Amemiya; C W Putnam; C G Groth
Journal:  Lancet       Date:  1971-07-10       Impact factor: 79.321

4.  Autoimmunity and immunosuppression.

Authors:  M C Berenbaum
Journal:  Proc R Soc Med       Date:  1967-11-01

5.  Effect of chemotherapy and immunotherapy on tumor-specific immunity in melanoma.

Authors:  M S Mitchell; M B Mokyr; J M Davis
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

6.  Evaluation of the immunosuppressive effects of cyclophosphamide in patients with multiple sclerosis.

Authors:  R J ten Berge; H K van Walbeek; P T Schellekens
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

7.  Whole-body hyperthermia decreases lung metastases in lung tumor-bearing mice, possibly via a mechanism involving natural killer cells.

Authors:  R N Shen; N B Hornback; H Shidnia; R E Shupe; Z Brahmi
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

8.  Presence of an enlarged pool of MOPC-315-specific cytotoxic T lymphocyte precursors in the thymuses of mice that eradicated a large MOPC-315 tumor as a consequence of low-dose melphalan therapy.

Authors:  M M Bartik; M C Ahn; B A Baumgartel; R L Hendricks; M B Mokyr
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

9.  Low-dose melphalan-induced shift in the production of a Th2-type cytokine to a Th1-type cytokine in mice bearing a large MOPC-315 tumor.

Authors:  L Gorelik; A Prokhorova; M B Mokyr
Journal:  Cancer Immunol Immunother       Date:  1994-08       Impact factor: 6.968

10.  Noninvasive ventilation for patients near the end of life: what do we know and what do we need to know?

Authors:  William J Ehlenbach; J Randall Curtis
Journal:  Crit Care Med       Date:  2008-03       Impact factor: 7.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.